![]() |
Proteomic and Metabolomic Approaches to Biomarker Discovery / edited by Haleem J. Issaq, Timothy D. Veenstra. -- 2nd ed. -- Amsterdam : Academic Press, 2020. – (58.17421 /P967ac /2nd ed.) |
Contents
Contributors
xi
Preface to the second edition xv
1. Biomarker discovery: Study design and
execution
2. Proteomic and mass spectrometry
technologies for biomarker discovery
3. Tissue sample preparation for proteomic
analysis
4. Sample preparation in global metabolomics
of biological fluids and tissues
5. Serum and plasma collection:
Preanalytical variables and standard operating procedures in biomarker research
6. Sample depletion, fractionation, and
enrichment for biomarker discovery
7. Current NMR strategies for biomarker
discovery
8. Gas chromatography/mass spectrometry-
based metabonomics
9. Liquid chromatographic methods combined
with mass spectrometry in metabolomics
10. Capillary electrophoresis-mass
spectrometry for proteomic and metabolic analysis
11. Associating 2-DE and CPLLs for
low-abundance protein discovery: A winning strategy
12. Two-dimensional difference in gel
electrophoresis for biomarker discovery
13. Affinity-targeting schemes for protein
biomarkers
14. Protein and metabolite identification
15. Quantitative proteomics in development
of disease protein biomarkers
16. Mass spectrometry and NMR spectroscopy
based quantitative metabolomics
17. Top-down mass spectrometry for protein
molecular diagnostics, structure analysis, and biomarker discovery
18. Using data-independent mass spectrometry
to extend detectable dynamic range without prior fractionation
19. Imaging mass spectrometry of intact
biomolecules in tissue sections
20. Mass spectrometry-based approach for
protein biomarker verification
21. Mass spectrometry metabolomic data
handling for biomarker discovery
22. Analytical methods and biomarker
validation
23. Multivariate analysis for metabolomics
and proteomics data
24. Cell surface protein enrichment for biomarker
and drug target discovery using mass spectrometry-based proteomics
25. Advances in lipidomics for cancer
biomarker discovery
26. Mass spectrometry for the identification
of protein biomarkers in urinary extracellular vesicles
27. Designing clinical studies for biomarker
discovery: The Design criteria